Table 1.
Donor ID* | DSM-IV diagnosis | Age (years) | Sex | Education years | ApoE4 genotype (yes/no) | CERAD score | Braak stage | NIA-Reagan | Analyzed region (PCx/TCx) |
---|---|---|---|---|---|---|---|---|---|
H14.09.024 | ND | 78 | M | 21 | N | 1 | 3 | 1 | Both |
H14.09.028 | ND | 78 | M | 16 | N | 2 | 3 | 2 | Both |
H14.09.094 | ND | 78 | M | 18 | N | 1 | 2 | 1 | Both |
H14.09.076 | ND | 78 | F | 14 | N | 1 | 2 | 1 | Both |
H14.09.016 | ND | 81 | M | 21 | Y | 2 | 3 | 2 | Both |
H14.09.074 | ND | 82 | F | 16 | N | 1 | 3 | 1 | Both |
H14.09.096 | ND | 84 | M | 12 | N | 2 | 3 | 2 | Both |
H14.09.060 | ND | 86 | F | 12 | N/A | 2 | 4 | 2 | Both |
H15.09.106 | ND | 86 | M | 14 | N | 0 | 2 | 1 | TCx |
H14.09.078 | ND | 87 | M | 16 | N | 0 | 1 | 1 | Both |
H14.09.080 | ND | 87 | M | 21 | N | 0 | 0 | 0 | Both |
H14.09.058 | ND | 88 | M | 14 | N | 1 | 1 | 1 | Both |
H14.09.062 | ND | 89 | F | 16 | Y | 1 | 3 | 1 | Both |
H14.09.072 | ND | 89 | F | 15 | N | 1 | 4 | 1 | Both |
H14.09.090 | ND | 89 | F | 12 | N | 1 | 5 | 2 | PCx |
H14.09.004 | ND | 90–94 | M | 14 | N | 1 | 3 | 1 | Both |
H14.09.014 | ND | 90–94 | M | 10 | N | 1 | 4 | 1 | Both |
H14.09.006 | ND | 90–94 | F | 14 | N | 0 | 3 | 1 | Both |
H14.09.030 | ND | 90–94 | F | 15 | Y | 3 | 3 | 2 | Both |
H14.09.032 | ND | 90–94 | F | 15 | N | 1 | 4 | 1 | Both |
H14.09.052 | ND | 90–94 | F | 14 | N | 1 | 2 | 1 | Both |
H15.09.104 | ND | 90–94 | F | 12 | N | 2 | 5 | 2 | Both |
H15.09.108 | ND | 90–94 | F | 12 | N | 3 | 4 | 2 | Both |
H14.09.046 | ND | 95–99 | M | 13 | N | 2 | 1 | 2 | Both |
H14.09.050 | ND | 95–99 | M | 8 | N | 3 | 3 | 2 | Both |
H14.09.070 | ND | 95–99 | M | 16 | N | 0 | 2 | 1 | Both |
H14.09.020 | ND | 95–99 | F | 18 | N | 2 | 3 | 2 | Both |
H14.09.102 | ND | 95–99 | F | 16 | N | 0 | 1 | 1 | Both |
H14.09.018 | AD | 79 | M | 18 | N | 0 | 2 | 1 | Both |
H15.09.110 | AD | 82 | F | 14 | N | 2 | 2 | 1 | Both |
H14.09.040 | AD | 85 | M | 12 | Y | 1 | 6 | 2 | Both |
H14.09.068 | AD | 85 | M | 16 | Y | 3 | 5 | 3 | Both |
H14.09.098 | AD | 86 | M | 9 | N | 3 | 6 | 3 | Both |
H14.09.044 | AD | 87 | F | 14 | N/A | 2 | 6 | 2 | TCx |
H14.09.022 | AD | 88 | M | 12 | N | 0 | 1 | 1 | Both |
H14.09.034 | AD | 88 | M | 16 | Y | 3 | 5 | 3 | Both |
H14.09.054 | AD | 89 | M | 9 | N | 1 | 3 | 1 | Both |
H14.09.002 | AD | 90–94 | M | 16 | Y | 0 | 1 | 1 | Both |
H14.09.082 | AD | 95–99 | M | 15 | N | 0 | 4 | 1 | Both |
H14.09.042 | AD | 95–99 | F | 11 | N/A | 3 | 5 | 3 | PCx |
H14.09.086 | AD | 95–99 | F | 14 | N | 3 | 6 | 3 | Both |
H14.09.010 | AD | 100 + | M | 16 | Y | 3 | 4 | 2 | Both |
H14.09.056 | AD | 100 + | F | 17 | N/A | 3 | 5 | 3 | Both |
H14.09.088 | AD | 100 + | F | 12 | N | 3 | 5 | 3 | Both |
*Histological images from the donors were obtained at the public database aging, dementia, and TBI study (http://aging.brain-map.org/overview/home). Donors are listed here with the same ID as coded at the online database
DSM-IV diagnostic and statistical manual of mental disorders, CERAD Consortium to Establish a Registry for Alzheimer’s Disease, NIA-Reagan National Institute on Aging and Ronald and Nancy Reagan Institute of the Alzheimer’s Association criteria, PCx parietal cortex, TCx temporal cortex, ND no dementia, AD Alzheimer’s disease